Replies to post #208791 on Biotech Values

[jbog]

I wonder if Teva uses a washable marker when the put a guys name on the CEO door.

Their problem is integrating Allergan, Copaxone has been history for awhile. It'll still be interesting to see what percentage of 40mg sales they retain.

[DewDiligence]

TEVA 4Q16 CC slides:

http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyNDcwNzd8Q2hpbGRJRD02NjAwNDk=